764 related articles for article (PubMed ID: 18250181)
1. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
3. Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease.
Jensen D; Alsuhail A; Viola R; Dudgeon DJ; Webb KA; O'Donnell DE
J Pain Symptom Manage; 2012 Apr; 43(4):706-19. PubMed ID: 22168961
[TBL] [Abstract][Full Text] [Related]
4. Effect of tiotropium bromide on the cardiovascular response to exercise in COPD.
Travers J; Laveneziana P; Webb KA; Kesten S; O'Donnell DE
Respir Med; 2007 Sep; 101(9):2017-24. PubMed ID: 17475459
[TBL] [Abstract][Full Text] [Related]
5. Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.
Guenette JA; Raghavan N; Harris-McAllister V; Preston ME; Webb KA; O'Donnell DE
Respir Med; 2011 Dec; 105(12):1836-45. PubMed ID: 21917440
[TBL] [Abstract][Full Text] [Related]
6. Effect of indacaterol on dynamic lung hyperinflation and breathlessness in hyperinflated patients with COPD.
Beeh KM; Wagner F; Khindri S; Drollmann AF
COPD; 2011 Oct; 8(5):340-5. PubMed ID: 21793716
[TBL] [Abstract][Full Text] [Related]
7. Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD.
Peters MM; Webb KA; O'Donnell DE
Thorax; 2006 Jul; 61(7):559-67. PubMed ID: 16467067
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.
Guenette JA; Webb KA; O'Donnell DE
Respir Med; 2013 May; 107(5):708-16. PubMed ID: 23421968
[TBL] [Abstract][Full Text] [Related]
9. Physiological responses to high intensity, constant-load arm exercise in COPD.
McKeough ZJ; Alison JA; Speers BA; Bye PT
Respir Med; 2008 Mar; 102(3):348-53. PubMed ID: 18063355
[TBL] [Abstract][Full Text] [Related]
10. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease.
Ong KC; Kor AC; Chong WF; Earnest A; Wang YT
Am J Respir Crit Care Med; 2004 May; 169(9):1028-33. PubMed ID: 14977622
[TBL] [Abstract][Full Text] [Related]
11. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
12. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease.
Stevenson NJ; Calverley PM
Thorax; 2004 Aug; 59(8):668-72. PubMed ID: 15282386
[TBL] [Abstract][Full Text] [Related]
13. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
[TBL] [Abstract][Full Text] [Related]
14. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
15. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease.
Ofir D; Laveneziana P; Webb KA; Lam YM; O'Donnell DE
Am J Respir Crit Care Med; 2008 Mar; 177(6):622-9. PubMed ID: 18006885
[TBL] [Abstract][Full Text] [Related]
17. Randomised, placebo controlled trial of nebulised furosemide for breathlessness in patients with cancer.
Wilcock A; Walton A; Manderson C; Feathers L; El Khoury B; Lewis M; Chauhan A; Howard P; Bell S; Frisby J; Tattersfield A
Thorax; 2008 Oct; 63(10):872-5. PubMed ID: 18408049
[TBL] [Abstract][Full Text] [Related]
18. Endurance shuttle walking test: responsiveness to salmeterol in COPD.
Brouillard C; Pepin V; Milot J; Lacasse Y; Maltais F
Eur Respir J; 2008 Mar; 31(3):579-84. PubMed ID: 18057052
[TBL] [Abstract][Full Text] [Related]
19. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.
O'Donnell DE; Flüge T; Gerken F; Hamilton A; Webb K; Aguilaniu B; Make B; Magnussen H
Eur Respir J; 2004 Jun; 23(6):832-40. PubMed ID: 15218994
[TBL] [Abstract][Full Text] [Related]
20. Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease.
Mainguy V; Girard D; Maltais F; Saey D; Milot J; Sénéchal M; Poirier P; Provencher S
Am J Cardiol; 2012 Jul; 110(2):258-63. PubMed ID: 22497677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]